ImmunoGen Transitions To Commercial Stage With Elahere Launch

 
• By Jessica Merrill

The antibody-drug conjugate was approved by the US FDA for the treatment of FRα-positive, platinum-resistant epithelial ovarian cancer.

applause
ImmunoGen's first wholly owned drug was approved by FDA • Source: Shutterstock

More from Anticancer

More from Therapy Areas